• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌感染导致的住院时间和费用:一项批判性综述。

Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.

作者信息

Gabriel L, Beriot-Mathiot A

机构信息

Institute of Pharmaceutical and Biological Sciences, University Lyon 1, Lyon, France.

Sanofi Pasteur, Lyon, France.

出版信息

J Hosp Infect. 2014 Sep;88(1):12-21. doi: 10.1016/j.jhin.2014.04.011. Epub 2014 May 17.

DOI:10.1016/j.jhin.2014.04.011
PMID:24996516
Abstract

In most healthcare systems, third-party payers fund the costs for patients admitted to hospital for Clostridium difficile infection (CDI) whereas, for CDI cases arising as complications of hospitalization, not all related costs are refundable to the hospital. We therefore aimed to critically review and categorize hospital costs and length of hospital stay (LOS) attributable to Clostridium difficile infection and to investigate the economic burden associated with it. A comprehensive literature review selected papers describing the costs and LOS for hospitalized patients as outcomes of CDI, following the use of statistics to identify costs and LOS solely attributable to CDI. Twenty-four studies were selected. Estimated attributable costs, all ranges expressed in US dollars, were $6,774-$10,212 for CDI requiring admission, $2,992-$29,000 for hospital-acquired CDI, and $2,454-$12,850 where no categorization was made. The ranges for LOS values were 5-13.6, 2.7-21.3, and 2.8-17.9 days, respectively. The categorization of CDI attributable costs allows budget holders to anticipate the cost per CDI case, a perspective that should enrich the design of appropriate incentives for the various budget holders to invest in prevention so that CDI prevention is optimized globally.

摘要

在大多数医疗保健系统中,第三方支付者为因艰难梭菌感染(CDI)入院的患者支付费用,然而,对于因住院并发症而出现的CDI病例,并非所有相关费用都可退还给医院。因此,我们旨在严格审查并分类归因于艰难梭菌感染的医院成本和住院时间(LOS),并调查与之相关的经济负担。一项全面的文献综述筛选出描述住院患者因CDI导致的成本和住院时间的论文,通过统计方法确定仅归因于CDI的成本和住院时间。共选取了24项研究。估计的归因成本(均以美元表示)为:因CDI需要入院的为6774美元至10212美元,医院获得性CDI为2992美元至29000美元,未分类的为2454美元至12850美元。住院时间值的范围分别为5至13.6天、2.7至21.3天和2.8至17.9天。对CDI归因成本进行分类使预算管理者能够预估每个CDI病例的成本,这一视角应丰富为各类预算管理者设计适当激励措施的思路,促使他们投资于预防工作,从而在全球范围内优化CDI的预防工作。

相似文献

1
Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.艰难梭菌感染导致的住院时间和费用:一项批判性综述。
J Hosp Infect. 2014 Sep;88(1):12-21. doi: 10.1016/j.jhin.2014.04.011. Epub 2014 May 17.
2
Attributable Cost of Clostridium difficile Infection in Pediatric Patients.艰难梭菌感染患儿的归因成本。
Infect Control Hosp Epidemiol. 2017 Dec;38(12):1472-1477. doi: 10.1017/ice.2017.240. Epub 2017 Nov 27.
3
Attributable costs and length of stay of hospital-acquired : A population-based matched cohort study in Alberta, Canada.医院获得性感染的归因成本和住院时间:加拿大艾伯塔省基于人群的匹配队列研究。
Infect Control Hosp Epidemiol. 2019 Oct;40(10):1135-1143. doi: 10.1017/ice.2019.178. Epub 2019 Jul 25.
4
Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.从国家医疗保险角度看2014年法国医院艰难梭菌感染的负担
Infect Control Hosp Epidemiol. 2017 Aug;38(8):906-911. doi: 10.1017/ice.2017.114.
5
Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.医院获得性艰难梭菌感染的归因负担:一项倾向评分匹配研究。
Infect Control Hosp Epidemiol. 2013 Jun;34(6):588-96. doi: 10.1086/670621. Epub 2013 Apr 19.
6
Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.2012 年至 2016 年期间美国住院患者中艰难梭菌(艰难梭菌)感染的负担。
J Hosp Infect. 2019 Jun;102(2):135-140. doi: 10.1016/j.jhin.2019.01.020. Epub 2019 Jan 25.
7
Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.艰难梭菌感染所致固定和可变医院成本评估:机构激励措施及未来研究方向
J Hosp Infect. 2017 Apr;95(4):415-420. doi: 10.1016/j.jhin.2017.01.016. Epub 2017 Feb 2.
8
Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.艰难梭菌感染在多所学术医疗中心队列中的经济影响。
Pharmacotherapy. 2011 Jun;31(6):546-51. doi: 10.1592/phco.31.6.546.
9
The economic burden of Clostridium difficile.艰难梭菌的经济负担。
Clin Microbiol Infect. 2012 Mar;18(3):282-9. doi: 10.1111/j.1469-0691.2011.03571.x. Epub 2011 Jun 10.
10
Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.住院患者中初次与复发性艰难梭菌感染的经济负担:一项前瞻性队列研究。
J Hosp Infect. 2016 Jul;93(3):286-9. doi: 10.1016/j.jhin.2016.04.004. Epub 2016 Apr 20.

引用本文的文献

1
Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: the RECUR Germany study.估算 2015-2019 年艰难梭菌感染和复发的超额死亡率和经济负担:德国 RECUR 研究。
BMC Infect Dis. 2024 May 31;24(1):548. doi: 10.1186/s12879-024-09422-w.
2
Economic Burden of Clostridioides difficile Infection in European Countries.欧洲国家艰难梭菌感染的经济负担。
Adv Exp Med Biol. 2024;1435:1-12. doi: 10.1007/978-3-031-42108-2_1.
3
Infection in an Italian Tertiary Care University Hospital: A Retrospective Analysis.
意大利一家三级护理大学医院的感染情况:一项回顾性分析。
Antibiotics (Basel). 2023 Apr 30;12(5):837. doi: 10.3390/antibiotics12050837.
4
Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective.从美国医院角度看,使用奥马环素针对性替代当前符合指南的住院治疗药物,用于治疗有感染高风险的成人社区获得性细菌性肺炎住院患者的潜在成本节约:医疗决策分析模型的结果
Antibiotics (Basel). 2021 Oct 1;10(10):1195. doi: 10.3390/antibiotics10101195.
5
Costs Associated with the Treatment of Clostridioides Difficile Infections.艰难梭菌感染治疗相关成本。
Int J Environ Res Public Health. 2021 Jul 19;18(14):7647. doi: 10.3390/ijerph18147647.
6
A passive monitoring tool using hospital administrative data enables earlier specific detection of healthcare-acquired infections.一种利用医院管理数据的被动监测工具能够更早地对医疗保健相关感染进行特异性检测。
J Hosp Infect. 2020 Nov;106(3):562-569. doi: 10.1016/j.jhin.2020.07.031. Epub 2020 Aug 1.
7
Incidence and economic burden of infection in Ontario: a retrospective population-based study.安大略省感染的发病率和经济负担:一项回顾性基于人群的研究。
CMAJ Open. 2020 Jan 30;8(1):E16-E25. doi: 10.9778/cmajo.20190018. Print 2020 Jan-Mar.
8
Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis.艰难梭菌感染的发生率和结局:系统评价和荟萃分析。
JAMA Netw Open. 2020 Jan 3;3(1):e1917597. doi: 10.1001/jamanetworkopen.2019.17597.
9
Direct cost of health care for individuals with community associated Clostridium difficile infections: A population-based cohort study.社区相关性艰难梭菌感染个体的医疗保健直接成本:基于人群的队列研究。
PLoS One. 2019 Nov 8;14(11):e0224609. doi: 10.1371/journal.pone.0224609. eCollection 2019.
10
Epidemiology of infections, France, 2010 to 2017.2010 年至 2017 年法国传染病的流行病学。
Euro Surveill. 2019 Aug;24(35). doi: 10.2807/1560-7917.ES.2019.24.35.1800638.